𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment options for hydroxyurea-refractory disease complications in myeloproliferative neoplasms: JAK2 inhibitors, radiotherapy, splenectomy and transjugular intrahepatic portosystemic shunt

✍ Scribed by Elena Mishchenko; Ayalew Tefferi


Book ID
114794805
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
94 KB
Volume
85
Category
Article
ISSN
0902-4441

No coin nor oath required. For personal study only.